This article explores the challenges of oral NMN (Nicotinamide Mononucleotide) absorption and how liposomal technology offers a transformative solution. It explains why NMN’s traditional forms suffer from low bioavailability due to digestive degradation and poor membrane permeability. Through detailed discussion of liposomal delivery mechanisms—such as enhanced protection, improved absorption, and controlled release—the article positions liposomal NMN as a breakthrough innovation with significant advantages for B2B buyers, supplement brands, and end users. Research-backed data and clear comparisons underscore liposomal NMN’s potential to redefine market standards in bioavailability and user experience.